2/28/19: Closed 1/2 Position at 1.3 2/25/19: Added .93 1/7/19: Bought starter core position .63 Initial Target 1.3
$EVIO has moved into previous congestion area and 200ma 2/21/19 Sold 1/2 position .76 2/6/19 Bot $EVIO .435. Initial target .58. $EVIO pick-and shovel play in the Lab/Testing verticle. All LP products must be tested before being sold.
$GTBIF breaking out from 3 month base. Short Term Target 18.9 Int. Term Target 22.3 $GTBIF part of $US MSO Basket, +29%YTD
Israeli Cannabis BioPharma (Parkinson’s). Drug delivery + Pain Management + Novel Technology Intec Pharma May Have a Blockbuster Parkinson’s Foundation Will Gather Experts to Study Cannabis as Disease Therapy 2/19/2019 News:
2/6/19 Bot $EVIO .435. Initial target .58. $EVIO pick-and shovel play in the Lab/Testing verticle. All LP products must be tested before being sold. Recent news: EVIO Canada’s Keystone Labs Ready for Federal Regulatory Cannabis Pesticide Contamination Testing EVIO Labs Receives Provisional License from Massachusetts Cannabis Control Commission
Update 1/7/18: Sold trading position .375 ave. 1/2/19 Alert: Added to $IMLFF .255 average. Full Core and Trading Position. Target for Trading Position .38~. $IMLFF is a Bio Synthetic play (Ex. $CRON/$MO)
Bot $GRWC .072, Trade only. Target .11 – .12, Very thin, due your own DD.
1/7/19: Bought starter core position $CNXXF .63..very thin..due your own DD 4Front Holdings CEO on Cannex Capital Group (CNSX:CNNX) (OTC:CNXXF) Transformational Business Combination
$TGIFF now past heavy end of year tax-loss selling pressure. Great r/r for this Farm Bill play.
$GTBIF now past heavy end of year tax-loss selling. Trying to break out from 3 month declining wedge.